Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
Phone+49 (89) 998 992-0



Maximilianstr. 35, Entrance C
Munich, +49 (89) 998 992-0, DEU
Quebec, CAN
2 Place Alexis Nihon, Suite 902
3500 Blvd De Maisonneuve West, Westmount
Quebec, H3Z 3C1, CAN
Dubai, ARE
DIFC Gate Village, Building 4
Dubai, ARE


Managing Partner - Munich & Boston
General Partner
General Partner
General Partner
General Partner
Managing Director
Show All People


TVM Capital

TVM Capital is a global venture and growth capital firm with a 25 year operating track record. From their headquarters in Munich, and their offices in Boston and most recently also New York, they have financed more than 240 emerging companies in technology and the life sciences. During the last 15 years they have become increasingly specialized in these two attractive high-growth sectors. Their key objective as investors is to enhance company growth by harnessing the power to innovate at all levels – technological, strategic, marketing and geographical - incorporating effective international management and securing adequate financial backing.

Recent Milestones


Company Date Round Size Participants
Rapid Micro Biosystems 4/2014Venture Round$6M5
invendo medical 3/2014Venture Round$28M4
Ixchelsis 8/2013Private Equity1
Rapid Micro Biosystems 6/2013Series B$32.6M5
Kaneq Bioscience 1/2013Venture Round1
Definiens 10/2012Venture Round€10M2
bluebird bio 7/2012Series D$60M7
Argos Therapeutics 4/2012Series D$25M5
Probiodrug 1/2012Venture Round€15M6
bluebird bio 4/2011Venture Round$30M5
f-star Biotech 4/2011Venture Round€15M7
Cambridge Broadband Networks 12/2010Venture Round$16.5M5
Anchor Therapeutics 8/2010Series B$10M3
Cerenis Therapeutics 7/2010Series C€40M7
DIREVO Industrial Biotechnology 4/2010Series D$8.1M2
VPIsystems 3/2010Venture Round$4M5
bluebird bio 3/2010Series B$35M5
DIREVO Industrial Biotechnology 2/2010Venture Round€6M2
Probiodrug 11/2009Series B$54M8
Ubidyne 8/2009Series B$43M4
Rapid Micro Biosystems 8/2009Series A$18.6M4
Proteon Therapeutics 5/2009Series B$50M8
Cambridge Broadband Networks 2/2009Venture Round$7.5M4
Extend Media 12/2008Series C$10M3
Silicon Hive 10/2008Venture Round$7M3
CommProve 9/2008Venture Round$14M3
SpePharm 8/2008Venture Round€26M3
BitWave 8/2008Series B$10.2M3
Arteris 5/2008Series C$7.5M5
Winbox Technologies 5/2008Series A$1.56M1
Concert Pharmaceuticals 4/2008Series C$37M12
CoreOptics 4/2008Venture Round$25M8
Albireo 2/2008Series A$40M2
Vivendy Therapeutics 1/2008Venture Round$30.5M2
Ascent Therapeutics 11/2007Series A$19M3
DIREVO Industrial Biotechnology 10/2007Series C$16.8M7
Proteon Therapeutics 9/2007Series A$12M4
Arteris 6/2007Series B$8.1M4
Netviewer 5/2007Venture Round$12.2M2
Silicon Hive 4/2007Series A$10M3
Extend Media 4/2007Series B$12M3
Hymite 1/2007Series B$11.5M4
Concert Pharmaceuticals 11/2006Series B$48.5M8
RenaMed Biologics 9/2006Venture Round$40M9
Concert Pharmaceuticals 7/2006Series A$10M5
CoreOptics 7/2006Venture Round$28M6
Cambridge Broadband Networks 1/2006Series D$9M3
Impress Software Solutions 9/2005Series C$10M5
Ubidyne 9/2005Series A$15.5M2
Amnis 8/2005Series C$11.3M5
Sirtris Pharmaceuticals 3/2005Series B$27M6
VPIsystems 3/2005Series C$9M7
Aventeon 2/2005Series B$5M3
Sirtris Pharmaceuticals 12/2004Series A$13M5
BitWave 1/2004Series A$13M3


Sources [edit]
  1. SEC ( [edit]
  2. Invendo Medical Closes $28M Round ( [edit]
  3. Ixchelsis Recives Investment From TVM Life Science Ventures VII ( [edit]
  4. Rapid Micro Biosystems Raises $32.6M In Series B Financing ( [edit]
  5. TVM Life Science Ventures VII announces first investment: Kaneq Bioscience Ltd. ( [edit]
  6. Definiens AG Raises 10M in Funding ( [edit]
  7. bluebird bio Secures $60 Million in Oversubscribed Financing ( [edit]
  8. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012 ( [edit]
  9. Probiodrug Raises €15M in Funding ( [edit]
  10. bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team ( [edit]
  11. f-star raises €15M in a New Financing led by SR One ( [edit]
  12. Cambridge Broadband Networks Raises $16.5M in Funding ( [edit]
  13. Anchor Therapeutics Secures $10 Million Series B Financing to Advance Pepducin Drug Candidates ( [edit]
  14. Cerenis Therapeutics raises EUR 40 million in series C financing ( [edit]
  15. Direvo, GmbH: Series D $8.1M ( [edit]
  16. EDGAR [edit]
  17. Genetix raises $35M to advance gene therapies ( [edit]
  18. DIREVO Industrial Biotechnology Raises € 6 Million ( [edit]
  19. Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million) ( [edit]
  20. Ubidyne Secures $14.4 Million from Gimv and Current Investors to Complete $43 Million Series B Financing ( [edit]
  21. Rapid Micro Biosystems, Inc.: Series A $18.6M ( [edit]
  22. Proteon Therapeutics Completes Second Closing of Equity Financing ( [edit]
  23. Cambridge secures $7.5m financing ( [edit]
  24. ExtendMedia Raises $10M for Video Platforms ( [edit]
  25. Intel leads $7 million investment in Silicon Hive ( [edit]
  26. CommProve Secures New Financing of $14 Million ( [edit]
  27. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare enter into €26 Million Financing of SpePharm ( [edit]
  28. BitWave Semiconductor Closes Successful $10M B-round Funding ( [edit]
  29. Networking chip firm Arteris raises $7.5 million ( [edit]
  30. IPTV company Winbox gets TVM Capital funding ( [edit]
  31. Capital Funding Report [edit]
  32. CoreOptics Lands $25M ( [edit]
  33. Albireo Announces Second Closing of Series A Financing ( [edit]
  34. Capital Funding Report [edit]
  35. SEC ( [edit]
  36. DIREVO raises Euro 12 Million (USD 16.8 Million) in Series C Financing ( [edit]
  38. Arteris Completes $8.1M Series B Investment Round ( [edit]
  39. Netviewer Press Release. ( [edit]
  40. Silicon Hive – a venture in programmable semiconductor IP - spins out from Philips ( [edit]
  41. ExtendMedia Nets $12M ( [edit]
  42. Hymite has received over $11.5 million to support its development of compact silicon-based packaging for high-power LEDs. ( [edit]
  43. Concert Pharmaceuticals Raises $48.5 Million in Series B Financing ( [edit]
  44. RenaMed Biologics Secures $40 Million in Private Equity Financing ( [edit]
  45. Concert Pharmaceuticals, Inc.,â„¢ Announces Financing of its Series A Round ( [edit]
  46. CoreOptics Nabs Another $28M ( [edit]
  48. Impress Software pulls in $10M in venture cash Read more: Impress Software pulls in $10M in venture cash - Boston Business Journal ( [edit]
  49. EDGAR [edit]
  50. Amnis Closes Oversubscribed $11.25M Series C Round ( [edit]
  51. Sirtris Pharmaceuticals closes $27M second round ( [edit]
  53. EDGAR [edit]
  54. Sirtris closes $13 million financing ( [edit]
  55. Bitwave raises $10 million for reconfigurable transceiver chips ( [edit]
Edit This Page
Last Edited 4/15/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy